medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2013-4-2-36-41medsovet-1001Research ArticleГАСТРОЭНТЕРОЛОГИЯGASTROENTEROLOGYЛечение гастроэзофагеальной рефлюксной болезни: краткий обзор рекомендаций Американской гастроэнтерологической ассоциации (часть I)Treatment of gastroesophageal reflux disease: a brief overview of the recommendations of the American Gastroenterological Association (Part I)ПимановC. И.PimanovS. I.noemail@neicon.ruВГМУ, ВитебскРоссияVitebsk State Medical University, VitebskRussian Federation20133012201304-23641Copyright © Пиманов C.И., 20132013Пиманов C.И.Pimanov S.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1001

В статье приводится краткий обзор рекомендаций Американской гастроэнтерологической ассоциации 2013 г. по диагностике и лечению гастроэзофагеальной рефлюксной болезни (ГЭРБ).

The article is a brief overview of the recommendations of the American Gastroenterological Association in 2013 for diagnosis and treatment of gastroesophageal reflux disease (GERD).

гастроэзофагеальная рефлюкс-ная болезньпищеводингибиторы протонной помпыпищевод Барреттаэрозивный эзофагитgastroesophageal reflux diseaseesophagusproton pump inhibitorsBarrett's esophaguserosive esophagitisReferencesPeery A.F., Dellon E.S., Lund J. еt al. Burden of Gastrointestinal Disease in the United States: 2012 Update // Gastroenterology. – 2012. – Vol. 143, № 5. – P. 117987.Peery A.F., Dellon E.S., Lund J. еt al. Burden of Gastrointestinal Disease in the United States: 2012 Update // Gastroenterology. – 2012. – Vol. 143, № 5. – P. 117987.Katz P.O., Gerson L.B., Vela M.F. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease // Am. J. Gastroenterol. – 2013. – Vol. 108. – P.:308–8.Katz P.O., Gerson L.B., Vela M.F. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease // Am. J. Gastroenterol. – 2013. – Vol. 108. – P.:308–8.Rubenstein J.H, Scheiman J.M., Sadeghi S. et al. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies // Am. J. Gastroenterol. – 2011. – Vol. 106. – P. 254 – 60.Rubenstein J.H, Scheiman J.M., Sadeghi S. et al. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies // Am. J. Gastroenterol. – 2011. – Vol. 106. – P. 254 – 60.Кайбышева В.О., Трухманов А.С., Ивашкин В.Т. Гастроэзофагеальная рефлюксная болезнь, резистентная к терапии ингибиторами протонной помпы // Росс. журн. гастроэнтерол., гепатологии, колопроктологии. – 2011. – № 4. – C. 413.Кайбышева В.О., Трухманов А.С., Ивашкин В.Т. Гастроэзофагеальная рефлюксная болезнь, резистентная к терапии ингибиторами протонной помпы // Росс. журн. гастроэнтерол., гепатологии, колопроктологии. – 2011. – № 4. – C. 413.Solaymany-Dodaran M., Card T.R., West О. Cause-Specific Mortality of People With Barrett’s Esophagus Compared With the General Population: A Population-Based Cohort Study // Gastroenterology. – 2013. – Vol. 144, № 7. – P. 135783.Solaymany-Dodaran M., Card T.R., West О. Cause-Specific Mortality of People With Barrett’s Esophagus Compared With the General Population: A Population-Based Cohort Study // Gastroenterology. – 2013. – Vol. 144, № 7. – P. 135783.Vakil N., van Zanten S.V. , Kahrilas P. et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus // Am. J. Gastroenterol. – 2006. – Vol.101. – P.1900–20.Vakil N., van Zanten S.V. , Kahrilas P. et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus // Am. J. Gastroenterol. – 2006. – Vol.101. – P.1900–20.Hunt R.H., Tytgat G.N., Malfertheiner P. et al. Whistler Consensus // J. Clin. Gastroenterol. – 2007. – Vol. 41. – P. S47–S50.Hunt R.H., Tytgat G.N., Malfertheiner P. et al. Whistler Consensus // J. Clin. Gastroenterol. – 2007. – Vol. 41. – P. S47–S50.Tytgat G.N., McColl K., Tack J. et al. New algorithm for the treatment of gastro-oesophageal reflux disease // Aliment. Pharmacol. Ther. – 2008. – Vol. 27. – P.249–56.Tytgat G.N., McColl K., Tack J. et al. New algorithm for the treatment of gastro-oesophageal reflux disease // Aliment. Pharmacol. Ther. – 2008. – Vol. 27. – P.249–56.Guyatt G.H., Oxman A.D., Vist G.E. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations // BMJ. – 2008. – Vol. 336. – P.924–6.Guyatt G.H., Oxman A.D., Vist G.E. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations // BMJ. – 2008. – Vol. 336. – P.924–6.Malfertheiner P., Megraud F., O'Morain C. et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report // Gut. – 2012. – Vol.61. – P.646–64.Malfertheiner P., Megraud F., O'Morain C. et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report // Gut. – 2012. – Vol.61. – P.646–64.Kaltenbach T , Crockett S , Gerson LB . Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach // Arch. Intern. Med. – 2006 – Vol. 166. – P. 965 – 71.Kaltenbach T , Crockett S , Gerson LB . Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach // Arch. Intern. Med. – 2006 – Vol. 166. – P. 965 – 71.Wileman S.M., McCann S., Grant A.M. et al. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults // Cochrane Database Syst. Rev. – 2010. – CD003243.Wileman S.M., McCann S., Grant A.M. et al. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults // Cochrane Database Syst. Rev. – 2010. – CD003243.Johnstone J., Nerenberg K., Loeb M. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia // Aliment. Pharmacol. Ther. – 2010. – Vol.31. – P.1165–77.Johnstone J., Nerenberg K., Loeb M. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia // Aliment. Pharmacol. Ther. – 2010. – Vol.31. – P.1165–77.Bhatt D.L., Scheiman J., Abraham N.S. et al. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents //Circulation. – 2008. – Vol. 118. – P.1894-1909.Bhatt D.L., Scheiman J., Abraham N.S. et al. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents //Circulation. – 2008. – Vol. 118. – P.1894-1909.Gerson L.B., McMahon D., Olkin I. et al. Lack of signifi cant interactions between clopidogrel and proton pump inhibitor therapy: meta-analysis of existing literature // Dig. Dis. Sci. – 2012. – Vol.57. – P.1304 – 13.Gerson L.B., McMahon D., Olkin I. et al. Lack of signifi cant interactions between clopidogrel and proton pump inhibitor therapy: meta-analysis of existing literature // Dig. Dis. Sci. – 2012. – Vol.57. – P.1304 – 13.Kwok C.S., Jeevanantham V., Dawn B. et al. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis // Int. J. Cardiol. – 2013 (in press).Kwok C.S., Jeevanantham V., Dawn B. et al. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis // Int. J. Cardiol. – 2013 (in press).Chen M., Wei J.F., Xu Y.N. et al. A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel //Cardiovasc. Ther. – 2012. – Vol.30. – P.e227 – 33.Chen M., Wei J.F., Xu Y.N. et al. A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel //Cardiovasc. Ther. – 2012. – Vol.30. – P.e227 – 33.Chen J., Chen S., Lian J. et al. Pharmacodynamic Impacts of Proton Pump Inhibitors on the Efficacy of Clopidogrel In Vivo – A Systematic Review // Clin. Cardiol. – 2013. – Vol.36, № 4. – P.184–9.Chen J., Chen S., Lian J. et al. Pharmacodynamic Impacts of Proton Pump Inhibitors on the Efficacy of Clopidogrel In Vivo – A Systematic Review // Clin. Cardiol. – 2013. – Vol.36, № 4. – P.184–9.Кобалава Ж.Д., Шаварова Е.К. Резистентная артериальная гипертония: новое и неизменно значимое // Сердце. – 2013. – Т.12, № 2. – С. 12332.Кобалава Ж.Д., Шаварова Е.К. Резистентная артериальная гипертония: новое и неизменно значимое // Сердце. – 2013. – Т.12, № 2. – С. 12332.

The authors declare that there are no conflicts of interest present.